Spots Global Cancer Trial Database for stage iiia
Every month we try and update this database with for stage iiia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer | NCT00434031 | Breast Cancer | docetaxel cyclophosphamid... trastuzumab liposomal doxor... | 18 Years - 65 Years | National Cancer Institute, Naples | |
| Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | NCT00226590 | Lung Cancer | Gemcitabine Carboplatin Paclitaxel Radiation | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases | NCT01114958 | Lung Neoplasms Neoplasm Metast... | Cisplatin, Thio... | 18 Years - | University of California, San Diego | |
| Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC) | NCT00960271 | Non Small Cell ... | EBUS | 18 Years - | University Hospital, Rouen | |
| Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC) | NCT00960271 | Non Small Cell ... | EBUS | 18 Years - | University Hospital, Rouen | |
| Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer | NCT02831582 | Arthralgia Breast Neoplasm... | Omega-3 Fatty A... Placebo | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases | NCT01114958 | Lung Neoplasms Neoplasm Metast... | Cisplatin, Thio... | 18 Years - | University of California, San Diego | |
| Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer | NCT03794544 | Resectable Early-stage NSCLC | Durvalumab Oleclumab Monalizumab Danvatirsen | 18 Years - 102 Years | MedImmune LLC | |
| Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab. | NCT04381494 | Unresectable St... | Multiparametric... | 18 Years - 130 Years | AstraZeneca | |
| Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer | NCT03794544 | Resectable Early-stage NSCLC | Durvalumab Oleclumab Monalizumab Danvatirsen | 18 Years - 102 Years | MedImmune LLC | |
| Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | NCT00226590 | Lung Cancer | Gemcitabine Carboplatin Paclitaxel Radiation | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer | NCT02835066 | Smoking Lung Neoplasms | Integrated Fitn... Psychosocial As... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
